126 related articles for article (PubMed ID: 31188744)
1. Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer.
Mansour-Ghanaei F; Joukar F; Baghaee M; Sepehrimanesh M; Hojati A
Biomol Concepts; 2019 May; 10(1):82-90. PubMed ID: 31188744
[TBL] [Abstract][Full Text] [Related]
2. Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults.
Kikuchi S; Wada O; Miki K; Nakajima T; Nishi T; Kobayashi O; Inaba Y
Cancer; 1994 Jun; 73(11):2695-702. PubMed ID: 8194008
[TBL] [Abstract][Full Text] [Related]
3. Serum pepsinogen in screening for gastric cancer.
Kodoi A; Yoshihara M; Sumii K; Haruma K; Kajiyama G
J Gastroenterol; 1995 Aug; 30(4):452-60. PubMed ID: 7550854
[TBL] [Abstract][Full Text] [Related]
4. The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer.
Juan Cai W; Yin L; Kang Q; Chen Zeng Z; Liang Wang S; Cheng J
Sci Rep; 2017 Mar; 7():43536. PubMed ID: 28251999
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
Huang SC; Miki K; Furihata C; Ichinose M; Shimizu A; Oka H
Clin Chim Acta; 1988 Jun; 175(1):37-50. PubMed ID: 3168282
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
[TBL] [Abstract][Full Text] [Related]
7. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY
Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345
[TBL] [Abstract][Full Text] [Related]
8. Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis.
Sadjadi A; Yazdanbod A; Lee YY; Boreiri M; Samadi F; Alizadeh BZ; Islami F; Fyfe V; Babaei M; Namazi MJ; Going JJ; Sotoudeh M; de Bock GH; Malekzadeh R; Derakhshan MH
PLoS One; 2013; 8(9):e74440. PubMed ID: 24098650
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area.
Gantuya B; Oyuntsetseg K; Bolor D; Erdene-Ochir Y; Sanduijav R; Davaadorj D; Tserentogtokh T; Uchida T; Yamaoka Y
Gastric Cancer; 2019 Jan; 22(1):104-112. PubMed ID: 29934751
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.
Aoki K; Misumi J; Kimura T; Zhao W; Xie T
J Epidemiol; 1997 Sep; 7(3):143-51. PubMed ID: 9337512
[TBL] [Abstract][Full Text] [Related]
11. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
12. Tissue and serum pepsinogen I and II in gastric cancer identified using immunohistochemistry and rapid ELISA.
Konishi N; Matsumoto K; Hiasa Y; Kitahori Y; Hayashi I; Matsuda H
J Clin Pathol; 1995 Apr; 48(4):364-7. PubMed ID: 7615858
[TBL] [Abstract][Full Text] [Related]
13. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
14. Role of Serum Pepsinogen I and II Ratio in Screening of Gastric Carcinoma.
Begum A; Baten MA; Begum Z; Ahsan MM; Rahman SF; Chowdhury F; Khan AH
Mymensingh Med J; 2017 Jul; 26(3):628-634. PubMed ID: 28919620
[TBL] [Abstract][Full Text] [Related]
15. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
Parthasarathy G; Maroju NK; Kate V; Ananthakrishnan N; Sridhar MG
Trop Gastroenterol; 2007; 28(4):166-70. PubMed ID: 18416347
[TBL] [Abstract][Full Text] [Related]
16. Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis.
Sanduleanu S; Bruïne AD; Biemond I; Stridsberg M; Jonkers D; Lundqvist G; Hameeteman W; Stockbrügger RW
Eur J Clin Invest; 2003 Feb; 33(2):147-54. PubMed ID: 12588289
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels.
Westerveld BD; Pals G; Lamers CB; Defize J; Pronk JC; Frants RR; Ooms EC; Kreuning J; Kostense PJ; Eriksson AW
Cancer; 1987 Mar; 59(5):952-8. PubMed ID: 3815274
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
[TBL] [Abstract][Full Text] [Related]
20. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]